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BACKGROUND: Surveillance of multiple congenital anomalies is considered to be more sensitive for the
detection of new teratogens than surveillance of all or isolated congenital anomalies. Current literature proposes
the manual review of all cases for classification into isolated or multiple congenital anomalies. METHODS: Mul-
tiple anomalies were defined as two or more major congenital anomalies, excluding sequences and
syndromes. A computer algorithm for classification of major congenital anomaly cases in the EUROCAT
database according to International Classification of Diseases (ICD)v10 codes was programmed, further
developed, and implemented for 1 year’s data (2004) from 25 registries. The group of cases classified with
potential multiple congenital anomalies were manually reviewed by three geneticists to reach a final agree-
ment of classification as ‘‘multiple congenital anomaly’’ cases. RESULTS: A total of 17,733 cases with major
congenital anomalies were reported giving an overall prevalence of major congenital anomalies at 2.17%.
The computer algorithm classified 10.5% of all cases as ‘‘potentially multiple congenital anomalies’’. After
manual review of these cases, 7% were agreed to have true multiple congenital anomalies. Furthermore, the
algorithm classified 15% of all cases as having chromosomal anomalies, 2% as monogenic syndromes, and
76% as isolated congenital anomalies. The proportion of multiple anomalies varies by congenital anomaly
subgroup with up to 35% of cases with bilateral renal agenesis. CONCLUSIONS: The implementation of the
EUROCAT computer algorithm is a feasible, efficient, and transparent way to improve classification of
congenital anomalies for surveillance and research. Birth Defects Research (Part A) 91:S44–S50, 2011.  2011
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INTRODUCTION
Methods for surveillance of multiple congenital anoma-
lies have been discussed since the thalidomide and
rubella epidemics and showed the importance of public
awareness of new teratogens. Surveillance of multiple
congenital anomalies is considered to be more sensitive
for detecting new teratogens than surveillance of all or
isolated congenital anomalies (Khoury et al., 1994). There
is fairly good agreement in the literature on a gross etiol-
ogic classification of congenital anomalies (Friedman,
1992, Rasmussen et al., 2003, Wellesley et al., 2005) for
surveillance and epidemiologic studies to be used in
combination with an anatomic approach based on organ
system or an approach based on presumed pathogenesis
(e.g., neural crest cell derived and vascular disruption).
The proposed classifications recognize the following cate-
gories: chromosomal syndromes, monogenic syndromes,
environmental syndromes, isolated congenital anomalies,
and multiple congenital anomalies.
For a congenital anomaly surveillance system, a num-
ber of problems in using such a classification arise. First,
the proposed classifications are based on individual case
review by medical geneticists, and the resources required
to review each case are beyond the capacity of a large
system. Second, interpretation of the classification can
vary by different medical geneticists, and it is, therefore,
difficult to standardize data for comparison of prevalence
rates or to pool data from registries each implementing
their own review. Third, there is little existing literature
on the prevalence of isolated and multiple congenital
anomalies where the rules for the interpretation of the
classification are explicit.
EUROCAT is a network of European registers of con-
genital anomalies carrying out epidemiologic surveillance
of congenital anomalies. It currently covers a population
of 1.7 million births per year. We developed a computer
algorithm based on the International Classification of Dis-
ease v10 (ICD10) codes which gives explicit coding rules
for classification and picks out a small subset of cases of
potential multiple congenital anomalies for individual
case review by medical geneticists. In this article, we
describe the algorithm, determine the proportion of cases
that require individual case review as potential multiple
congenital anomalies, give the average and range of Eu-
ropean prevalence of each of the four output categories,
and describe the ratio of isolated to multiply malformed
cases for different congenital anomaly subgroups.
METHODS
The EUROCAT registries are population-based and the
geographically-defined populations and the methods of
case ascertainment of EUROCAT have been described
elsewhere (www.eurocat-network.eu; Boyd et al., submit-
ted for publication). The registries are all based on multi-
ple sources of information including hospital records,
birth certificates, death certificates, and postmortem
examinations. Cases of congenital anomalies include live-
births, fetal deaths with gestational age 20 weeks, and
terminations of pregnancy for fetal anomaly after prena-
tal diagnosis of congenital anomalies. All structural
malformations, syndromes, and chromosomal anomalies
are included in the database, except minor and poorly
specified anomalies found on a list of exclusions (refer to
www.eurocat-network.eu).
Anonymous individual records are sent from the local
registries to the Central database once per year. Cases are
coded by coding experts at the local registries. Up to
eight anomalies and one syndrome are coded with ICD10
and British Pediatric Association extension. Most regis-
tries also give the name of the anomaly/syndrome in
text.
An ‘‘etiologic’’ classification variable designates the fol-
lowing groups (a case can belong to only one of these
groups):
a) Chromosomal syndromes: all cases where an unbal-
anced chromosomal anomaly has been diagnosed (clini-
cally and/or with a known karyotype), irrespective of
types of anatomically-defined component anomalies.
b) Monogenic and environmental syndromes: all cases
due to a single gene defect or a known environmental
teratogen, irrespective of types of component birth defect.
Further elaboration can separate out syndromes due
mainly to new mutations or to environmental teratogens,
depending on the purpose.
c) Isolated anomalies: all cases with one congenital
anomaly or with a known sequence where multiple con-
genital anomalies cascade as a consequence of a single
primary anomaly.
d) Multiple congenital anomalies: those babies with
two or more major congenital anomalies, where the pat-
tern of anomalies has not been recognized as part of a
syndrome or sequence. Associations are included, but
can be separated out when required.
Construction of the Algorithm
The ‘‘etiologic’’ classification was translated into a
computer algorithm which imposes a hierarchical classifi-
cation according to the ICD codes given for each case.
The final algorithm is given in the Appendix. The first
category is ‘‘chromosomal’’ to which a case is allocated if
it has a chromosomal ICD code. Only cases that are not
allocated to ‘‘chromosomal’’ are considered for the next
category, and a case is allocated to the last ‘‘potential
multiple anomaly’’ category only if it does not belong to
any of the preceding categories.
The algorithm has been derived iteratively since 2003.
The first version was created using the existing literature
(Friedman, 1992; Ka¨lle´n et al., 2001; Rasmussen et al.,
2003; Wellesley et al., 2005) and was used to generate a
list of cases of ‘‘potential multiples’’ (i.e., category M in
the algorithm) from birth years 1999 to 2003. Six hundred
cases (approximately 10%) were randomly chosen from
the list of potential multiples for case review by a panel
of three medical geneticists (E. Calzolari, I. Barisic, and
D. Wellesley). The following variables were included in
case review: registry, identification number, type of birth
(outcome of pregnancy), birth weight, gestational age,
prenatal or postnatal diagnosis, whether postmortem ex-
amination was available, karyotype, ICD10 anomaly
codes, text description of the anomalies as entered by
registry, and text description of anomalies as a direct
translation of the ICD code. Each member of the panel
reviewed all 600 case summaries and marked the cases
as multiple congenital anomalies or not. Cases where all
three panel members agreed were designated accordingly
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(240 multiple, 173 non-multiple). A meeting was held to
agree on all cases where there was initial disagreement
(187 cases of 600), all of which ended in agreement.
Three hundred six of the 600 cases were finally desig-
nated as multiple congenital anomalies, including 12
with a diagnosed recognized association (i.e., an associa-
tion diagnosed by the child’s clinician, not designated by
the panel on the basis of the combination of malforma-
tions present).
Non-multiples among the potential multiples are real-
located to one of the isolated categories in the algorithm,
or to the syndrome category if a syndrome diagnosis was
present without a specific ICD code.
On the basis of this exercise, the flowchart was revised
in several steps and new outputs of data were evaluated
for each revision. The main revisions were:
1. To incorporate instances where two codes within
the same organ system were commonly used which the
panel agreed indicated an isolated anomaly.
2. A number of known sequences were coded into the
flow chart as isolated congenital anomalies to further
decrease the number of potential multiple cases for
review.
3. The EUROCAT List of Minor Anomalies for Exclu-
sion was Extended
During the first meeting, it became evident that deci-
sions on difficult cases needed to be documented to
make future work consistent with previous agreements,
and these coding guidelines are available to the panel
when classifying potential multiples. Examples of these
decisions are:
 If the ICD code and local written text do not corre-
spond, we will rely on the written text. If the local writ-
ten text describes a minor anomaly or syndrome feature,
it is considered as such.
 Balanced chromosome rearrangements are disre-
garded in the classification, even if there is a possibility
that they may be associated with the major anomalies
recorded.
 We will not apply a syndrome diagnosis to multiple
congenital anomaly cases which have not been diagnosed
and coded as a syndrome by the local registry.
Computerized Implementation of the Algorithm
The EUROCAT Central Database has an extensive set of
associated software written in Access (Microsoft, USA)
that classifies cases into EUROCAT subgroups based on
ICD10 codes, and also applies the multiple congenital
anomaly algorithm, outputs the short case reviews for
medical geneticists, and allows the classification to be rein-
tegrated to the dataset. This is also available in the EURO-
CAT Data Management Program, the compatible software
used by local registries, so that the algorithm can also be
applied by each registry to their own data. In addition, we
proposed a new validation routine in EUROCAT Data
Management Program which prompts users to enter spe-
cific ICD codes rather than generalized ICD codes. During
the development of the algorithm, multiple checks were
made with case samples to make sure that cases had been
correctly classified by the algorithm, and that the propor-
tion of multiples changed in the expected direction.
Checking of ICD codes in registries with a high proportion
of potential multiple congenital anomalies revealed that,
in some instances, the registries were using major codes to
describe a minor anomaly as gauged from the text infor-
mation describing the anomaly. The Coding & Classifica-
tion Committee provided coding advice to counteract this
which is now available on the website. We considered also
coding some cases in the algorithm as ‘‘definite multiples’’
on the basis of combinations of only two codes which
always result in a multiple congenital anomaly classifica-
tion. However, we found that there were few combina-
tions which were frequent enough to make this exercise
worthwhile at present, and felt that there was an advant-
age in more extensive reviewing of coding of major
anomalies.
The most recent development is a web-based system
where the three geneticists can review the potential
multiple cases. At this final step to implement the sur-
veillance of multiple congenital anomalies, each case is
given the majority classification (two or three members
of the panel designate it as multiple). However, the
moderator (E. Garne) reviews the cases for disagree-
ment to check whether there are new concerns that
need discussion.
Data Analysis
The data presented here are from 25 EUROCAT Regis-
tries for births in 2004, being all full member registries
which had transmitted 2004 data at the time of the analy-
sis and had a prevalence rate above 1.5%.
The final algorithm was applied to the 2004 data to find
the number and prevalence of ‘‘potential multiples’’ as
well as all other hierarchical categories. All potential multi-
ple cases were reviewed by the three geneticists. Whereas
the algorithm subdivides the isolated category into neural
tube defects, cardiac defects, renal, and others, we present
here the entire isolated category combined.
RESULTS
From the 25 registries, 17,733 cases with major congeni-
tal anomalies were reported for 2004. The total number
of births covered was 818,759, giving an overall preva-
lence of major congenital anomalies at 2.17%.
Table 1 presents the final classification of cases using
the flow chart algorithm followed by manual review of
the 1862 potential multiple cases (10.5% of all cases).
Overall, 15% of all cases were classified as chromosomal
Table 1
Distribution of classification of cases with major
congenital anomalies from 25 EUROCAT registries in
2004 into four groups using EUROCAT multiple
congenital anomaly flowchart followed by manual
review of potential multiple cases
Number
%
of total
Prevalence
per 10,000
births
Chromosomal cases 2653 15 32.4
Syndromes 394 2 4.8
Isolated cases 13381 76 163.4
True multiples 1305 7 15.9
Total 17733 100 216.5
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anomalies, 2% as syndromes, 76% as isolated congenital
anomalies, and 7% as multiple congenital anomalies.
Prevalence of all four categories varied considerably by
registry Figure 1.
Of the 1862 potential multiple cases, 1305 (70%) were
agreed by the geneticists to be true multiple congenital
anomaly cases. Figure 1 presents the distribution of
potential multiple cases and true multiple cases by regis-
try. The proportion of true multiples among potential
multiples by registry varied from 31 to 100%.
Information on karyotyping (confirming non-chromo-
somal clinical diagnosis) was available in the central
database for 56% of potential multiple cases and 55% of
the true multiple cases.
Figure 2 presents classification of cases by anomaly
subgroup for 10 selected congenital anomaly subgroups
for illustration, all of these subgroups having more than
the average proportion of multiple congenital anomalies.
For congenital heart defects, 11% of all cases are classi-
fied as multiple congenital anomaly cases compared
to the subgroups with the highest proportions –24% for
hydrocephalus and 35% of cases with bilateral renal
agenesis.
Examples of disagreement among the three geneticists
are given in Table 2. Some disagreements were followed
by written rules for future decisions.
DISCUSSION
The EUROCAT algorithm for surveillance of multiple
congenital anomalies described in this article results in
approximately 10% of all registered cases being selected
for individual case review by medical geneticists. In our
surveillance system, this is a feasible load if prospectively
conducted. Potential multiple cases that are found to be
isolated on review usually have a rare or unusually
coded sequence, a complex malformation of the same
organ system not already included in the algorithm, or
Figure 1. Prevalence per 10,000 births of potential multiple con-
genital anomaly cases by whether they were finally classified as
true multiple congenital anomaly or non-multiple congenital
anomaly cases by registry. Figure 2. Proportion of cases classified as isolated, syndrome
(chromosomal, monogenic, and environmental) and multiple
congenital anomaly, by selected anomaly subgroup, all registries
combined. [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
Table 2
Examples of disagreement between the 3 geneticists
Major anomaly
codes
Minor anomaly
codes Written text Geneticist 1 Geneticist 2 Geneticist 3
Q210
Q788
Q3140
VSD
Laryngomalacia
Osteopenia
Isolated Multiple Isolated
Q0435
Q743
Hydranancephaly
Arthrogryposis Multiplex
Isolated Multiple Sequence
Q057
Q703
Lumbar spina bifida
Webbed toes
Multiple Isolated Multiple
Q042
Q029
Q556
Holoprosencephaly
Microcephaly
Micropenis
Multiple Sequence Multiple
Q660
Q650
Club feet
Hip dislocation, unilateral
Multiple Isolated Multiple
Q790
Q336
Q4330
Diaphragmatic hernia
Lung hypoplasia
Malrotation of cecum and colon
Multiple Sequence Multiple
VSD, ventricular septal defects.
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include minor or unspecified anomalies not obvious from
their codes. Moreover, we have found it useful to review
with a panel of three medical geneticists (rather than
by individuals), as this clarifies further areas of conten-
tion in the designation of ‘‘multiple congenital anomaly’’
status.
There are some conceptual problems with the designa-
tion of a ‘‘multiple congenital anomaly’’ baby/fetus. One
is the uncertain position of recognized associations such
as VATER (vertebral anomalies, anal atresia, tracheo-
esophageal fistula, esophageal atresia, or renal or radial
anomalies) in the classification scheme (Ka¨lle´n et al.,
2001). Our overall approach to this was that it was im-
portant, whatever decision was made, that it should be
explicit and consistent. We suspected that diagnosis of
VATER would not be made consistently across Europe or
over time, and we were reluctant to make paper diagno-
ses of VATER (and other associations) by case review of
registry data. We, therefore, kept associations in the
‘‘multiple’’ category. Nevertheless, over time, the classifi-
cation algorithm will need to change as associations
move to the syndrome category with the discovery of
genetic causes, as has occurred with the CHARGE associ-
ation. A second problem is whether minor anomalies
should be taken into account in designating a case as
multiple congenital anomalies. We recognize that minor
anomalies may be very important signs of teratogenic ex-
posure or dysmorphic syndromes (Holmes et al., 1987).
However, again we took a pragmatic approach and based
our classification only on two or more major anomalies,
on the basis that minor anomalies would be subject to
much more diagnostic reporting and coding variation.
We found considerable variation in the population
prevalence of multiple congenital anomaly cases between
participating registers, both before and after case review.
The main contributing factor which was resolved by case
review was differences in the coding of minor anomalies,
particularly where they do not have specific ICD10-BPA
codes and, therefore, cannot be recognized by the com-
puter as non-major. Case review also resolved other
‘‘coding style’’ differences, such as detailed coding of dif-
ferent manifestations of the same anomaly. We were per-
haps more surprised by the remaining wide variation in
prevalence of multiply malformed cases after conducting
the case review. One reason for this may be real differen-
ces in prevalence due to geographical differences in tera-
togenic exposures, or due to differences in the level of
diagnostic investigation leading to syndrome diagnoses.
We also note that a high prevalence after case review
was associated with a high proportion of ‘‘possibly mul-
tiply malformed’’ cases reclassified as isolated, which
points again to differences in registration practice and
the type of source medical records consulted to give
detailed descriptions of each case.
The European prevalence of chromosomal syndromes
of 32.4 per 10,000 births we find here is critically depend-
ent on the maternal age distribution in the population, as
well as the level of diagnostic investigation of multiple
congenital anomaly cases both prenatally and postnatally.
The prevalence of syndromes of 4.8 per 10,000 births
refers to syndromes usually diagnosed in the first year of
life (or prenatally).
The overall prevalence of isolated birth defects was
163.4 per 10,000 births. The ratio of isolated to multiple
congenital anomaly cases varied by type of defect (Fig. 2).
There is some debate for individual defect types whether
isolated and multiple congenital anomaly cases represent
etiologically distinct groupings. For example, for neural
tube defects, the United Kingdom and Ireland high preva-
lence rate was found to pertain to both isolated and mul-
tiple congenital anomaly neural tube defects, when site of
the defect was taken into account (Dolk et al., 1991),
although an American study (Yen et al., 1992) had
suggested etiologic differences between isolated and mul-
tiple congenital anomaly neural tube defects on the basis
of differences in sex ratio. We suggest that using our algo-
rithm to reduce workload and improve transparency of
classification, it will be possible in the future to look more
systematically at the epidemiologic differences between
isolated and multiple congenital anomaly cases of differ-
ent anatomic birth defect types.
Observations that many known teratogens (such as
rubella and thalidomide) cause multiple congenital
anomalies in a majority of cases have led to the practice
of conducting separate surveillance over time of all cases
with multiple congenital anomalies (Khoury et al., 1987),
both grouped together and by individual defect combina-
tions, to detect any changes due to new teratogens. Mul-
tiple congenital anomalies may result from a strong (high
dose) or complex insult to development disrupting many
processes at the time of the insult, or from a prolonged
insult spanning the sensitive period for development of
different organs. It is unlikely that such cases would be
etiologically totally distinct from cases with isolated
anomalies (and indeed the examples of rubella and thali-
domide show this to be the case), but as a group, they
may be more sensitive indicators of teratogenic insults
for surveillance. Our algorithm makes the implementa-
tion of multiple congenital anomalies monitoring much
more feasible for large populations.
We conclude that the implementation of the EURO-
CAT computer algorithm is a feasible, efficient, and
transparent way to improve classification of congenital
anomalies for surveillance and research.
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APPENDIX: MULTIPLE CONGENITAL
ANOMALY FLOW-CHART FOR MONITORING
OF MULTIPLE CONGENITAL ANOMALIES
Multiple Anomaly Flow-chart for Monitoring of
Multiple Anomalies
At the moment, this should be for the Central Database
only.
Only valid for years with ICD 10 codes.
Definition of a Multiple Anomaly Case
Two or more unrelated major structural malformations
that cannot be explained by an underlying syndrome or
sequence.
This means that the process of the flowchart is to find
cases with two or more codes within the Q chapter,
unless the case is transferred to other groups according
to the steps described below.
Name for Groups
C: chromosomal.
B: genetic syndrome, skeletal dysplasia, and monogenic
disorder.
N: neural tube defect isolated.
A: isolated cardiac.
R: isolated renal.
I: isolated other.
O: non-syndrome outside malformation chapter.
M: potential multiple anomalies.
T: teratogenic syndrome.
Minor, Unspecified, and Invalid Codes
The following codes are ignored in the flowchart, but
appear in individual case output:
Guide 1.3 list of minors post 2005 to be used for all
years.
No valid ICD code.
Group X contains cases with only the above-listed
codes.
Outside Q-chapter Codes (Except the Few Codes
Accepted in ‘‘all Anomalies’’)
These codes are ignored by the flowchart process but
appear in the individual case output.
The Flow-chart
For three and four digit codes mentioned here, the
coding also includes the codes with more digits.
Only Q-codes are valid for the process after step 2.
This is a hierarchical procedure.
Step 1
Exclude all cases with a chromosomal code.
Q90–Q93 except Q936, Q96–Q99,  Transfer to group
C.
Step 2
Exclude all cases with genetic syndrome codes, skeletal
dysplasia, and congenital skin disorder codes.
Q87, Q936, D821.
Q77, Q7800, Q782–788, Q7402.
Q80–Q82.
Q4471 Alagille syndrome, Q6190 Meckel–Gruber,
Q7484 Larsen syndrome.
Q751 Crouzon/craniofacial dysostosis, Q754 Mandibu-
lofacial dysostosis (Treacher Collin).
Q7581 Frontonasal dysplasia.
Excluding Q8703, Q8704, Q8706, Q8708, Q8724, Q8726
 Transfer to group B.
Step 3
Exclude all cases with a code for teratogenic syndrome
code.
Q86, P350, P351, P371  Transfer to group T.
Step 4
Exclude all cases with a heterogenous syndrome code.
Q761, Q7982, Q8581, Q8706  Transfer to group M.
Step 5
Exclude all cases with only neural tube defect codes.
Q00–Q01, Q05  Transfer to group N.
Step 6
Exclude all cases with codes only in cardiac chapter.
Q20–Q26  Transfer to group A.
Step 7
Exclude all cases with codes only in renal chapter.
Q60 – Q64, Q794  Transfer to group R.
Step 8
Exclude all cases with only one code within Q chapter.
Include known local coding variations/errors.
If Q00–Q01, Q05  Transfer to group N.
If Q20–Q26  Transfer to group A.
If Q60–Q64, Q794  Transfer to group R.
If only one other Q-code  Transfer to group I.
Step 9
Exclude all cases with codes only in eye chapter.
Q10–Q15  Transfer to group I.
Step 10
Exclude all cases with codes only with limb reduction
defects.
Q71–Q73  Transfer to group I.
Step 11
Exclude all cases with codes only for hypospadias.
Q54  Transfer to group I.
Step 12
Exclude all cases with codes only for polydactyly.
Q69  Transfer to group I.
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Step 13
Exclude all cases with codes only for reduction defects
of the brain.
Q04  Transfer to group I.
Step 14
Exclude all cases with codes only for hip anomalies.
Q65  Transfer to group I.
Step 15
Exclude all cases with codes only for syndactyly.
Q70  Transfer to group I.
Step 16
Exclude all cases with codes only for syndactyly 1
poly dactyly.
Q69 and Q70  Transfer to group I.
Step 17
Exclude all cases with codes only for small intestinal
atresia.
Q41  Transfer to group I.
Step 18
Exclude all cases with codes only for facial clefts.
Q35, Q36, Q37  Transfer to group I.
Step 19
Exclude all cases with the code for balanced chromo-
somal rearrangements and only one Q-code.
Q95.
If Q00–Q01, Q05, and Q95  Transfer to group N.
If Q20–Q26 and Q95  Transfer to group A.
If Q60–Q64, Q794, and Q95  Transfer to group R.
If only one other Q-code and Q95  Transfer to group I.
Step 20
Exclude all cases with only outside Q chapter codes
(without Q-codes).
Not beginning with Q.
D1810 accepted as outside Q-code  Transfer to group O.
Step 21
Exclude all known sequences or combinations of
anomalies without other anomaly codes.
(NB: Any one of these codes may be used more than
once – disregard duplicate codes.)
Spina bifida – talipes – hydrocephalus:
Q05 codedwith Q66 and/or Q03  Transfer to groupN.
Renal aplasia/dysplasia – lung hypoplasia – talipes:
Q601/Q606 coded with Q336 and/or Q66  Transfer to
group R.
Omphalocele/gastroschisis – malrotation of gut – small
intestinal atresia:
Q792/Q793 coded with Q433 and/or Q41  Transfer to
group I.
Anal atresia – rectovaginal fistula:
Q42 coded with Q522  Transfer to group I.
Diaphragmatic hernia – lung hypoplasia:
Q790 coded with Q336  Transfer to group I.
Anencephalus – adrenal hypoplasia:
Q000 coded with Q891  Transfer to group N.
Unspecified hydrocephalus – reduction defect of the
brain:
Q039 coded with Q04  Transfer to group I.
Unspecified hydrocephalus – Arnold–Chiari:
Q039 coded with Q070  Transfer to group I.
Neural tube defect – Arnold Chiari:
Q01 or Q05 coded with Q070  Transfer to group N.
Amniotic band sequence:
All cases with the code Q7980  Transfer to group I.
Caudal dysplasia sequence:
All cases with the code Q8980  Transfer to group I.
Sirenomelia sequence:
All cases coded with Q8724  Transfer to group I.
Cyclops sequence:
All cases coded with Q8703  Transfer to group I.
Pierre Robin sequence:
All cases coded with Q8708 as only code or with Q35–
Q37  Transfer to group I.
Holoprosencephaly – median cleft lip:
All cases coded with Q042 and Q361  Transfer to
group I.
Step 22
The remaining cases are group M: potential multiple
anomalies. Manual evaluation of all remaining cases
before final inclusion into multiple anomaly group – or
inclusion in one of the other groups.
Notes:
The need to output group M cases as individual case
lists with text description of anomalies as well as codes
plus variables: identification number, registry, year of
birth, type of birth, twin, gestational age, birth weight,
karyotype (including written text), and postmortem ex-
amination, when discovered.
For the website review of potential multiple cases, a
subgroup for ‘‘poorly specified cases’’ has to be added
(could go to group X).
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